droxidopa
Showing 1 - 25 of 37
Hypotension Trial (Midodrine Hydrochloride)
Not yet recruiting
- Hypotension
- Midodrine Hydrochloride
- (no location specified)
Apr 20, 2023
Parkinson Disease, Multiple System Atrophy, Progressive Supranuclear Palsy Trial in Loma Linda (Droxidopa, Placebo Oral Tablet)
Withdrawn
- Parkinson Disease
- +2 more
- Droxidopa
- Placebo Oral Tablet
-
Loma Linda, CaliforniaLoma Linda University Faculty Medical Offices - Neurology Clinic
Feb 14, 2022
Parkinson Disease, Fatigue, Parkinsonism Trial in Camden (Northera, Placebo Oral Tablet)
Terminated
- Parkinson Disease
- +2 more
- Northera
- Placebo Oral Tablet
-
Camden, New JerseyCooper University Health System
Nov 15, 2021
Postural Tachycardia Syndrome (POTS), Vasovagal Syncope (VVS), Fainting Trial in Hawthorne (Northera (Droxidopa), Placebo)
Active, not recruiting
- Postural Tachycardia Syndrome (POTS)
- +2 more
- Northera (Droxidopa)
- Placebo
-
Hawthorne, New YorkNew York Medical College/Bradhurst building
Apr 5, 2022
Menkes Disease, Occipital Horn Syndrome Trial in Columbus (Droxidopa, Placebo)
Recruiting
- Menkes Disease
- Occipital Horn Syndrome
- Droxidopa
- Placebo
-
Columbus, OhioNationwide Children's Hospital
Jul 22, 2021
Autonomic Nervous System Diseases, Orthostatic Hypotension, Dopamine Beta-Hydroxylase Deficiency Trial in Nashville (Droxidopa
Terminated
- Autonomic Nervous System Diseases
- +3 more
- Droxidopa Oral Product
-
Nashville, TennesseeVanderbilt University
Feb 28, 2022
Multiple System Atrophy Trial in France (L-Threo DOPS, )
Completed
- Multiple System Atrophy
- L-Threo DOPS
- placebo
-
Angers, France
- +12 more
Aug 24, 2020
Hypotension, Orthostatic, Hypotension, Spinal Cord Injuries Trial in Bronx, New York (Northera, Placebo)
Unknown status
- Hypotension, Orthostatic
- +2 more
- Northera
- Placebo
-
Bronx, New York
- +1 more
Feb 10, 2020
Parkinson Disease Trial in Nashville (Droxidopa, Carbidopa)
Completed
- Parkinson Disease
- Droxidopa
- Carbidopa
-
Nashville, TennesseeVanderbilt University Medical Center
Jan 14, 2020
Parkinson Disease, Neurogenic Orthostatic Hypotension Trial in Houston (Droxidopa, Placebo)
Unknown status
- Parkinson Disease
- Neurogenic Orthostatic Hypotension
- Droxidopa
- Placebo
-
Houston, TexasHouston Methodist Hospital
Sep 18, 2019
Parkinson Disease, Falls Patient Trial in Phoenix (Droxidopa, Placebo)
Unknown status
- Parkinson Disease
- Falls Patient
- Droxidopa
- Placebo
-
Phoenix, ArizonaBarrow Neurological Institute at St. Joseph's Hospital and Medic
Oct 25, 2019
Parkinson's Disease Trial in Japan (TVP-1012 1mg, TVP-1012 0.5mg, Placebo)
Completed
- Parkinson's Disease
- TVP-1012 1mg
- +2 more
-
Nagoya, Aichi, Japan
- +56 more
Feb 17, 2022
Parkinson's Disease Trial in Colorado Springs (droxidopa, Placebo)
Completed
- Parkinson's Disease
- droxidopa
- Placebo
-
Colorado Springs, ColoradoColorado Springs Neurological Associates
Jun 20, 2018
Primary Autonomic Failure, Dopamine Beta Hydroxylase Deficiency, Non-Diabetic Neuropathy Trial (Droxidopa)
Completed
- Primary Autonomic Failure
- +3 more
- Droxidopa
- (no location specified)
Feb 3, 2017
Parkinson Disease Trial in Phoenix (L-DOPS, Placebo)
Unknown status
- Parkinson Disease
- L-DOPS
- Placebo
-
Phoenix, ArizonaBarrow Neurological Institute/St. Joseph's Hospital and Medical
Feb 11, 2019
Postural Orthostatic Tachycardia Syndrome, Orthostatic Intolerance Trial in Boston (Droxidopa, Atenolol, Placebos)
Terminated
- Postural Orthostatic Tachycardia Syndrome
- Orthostatic Intolerance
- Droxidopa
- +2 more
-
Boston, Massachusetts
- +1 more
Apr 13, 2017
Parkinson's Disease, Freezing of Gait, Cognitive Ability, General Trial in Chicago, West Bloomfield (Droxidopa, sugar pill)
Unknown status
- Parkinson's Disease
- +2 more
- Droxidopa
- sugar pill
-
Chicago, Illinois
- +1 more
Nov 2, 2016
Dopamine Beta Hydroxylase (DBH) Deficiency Trial in Nashville (droxidopa)
Approved for marketing
- Dopamine Beta Hydroxylase (DBH) Deficiency
- droxidopa
-
Nashville, TennesseeVanderbilt University Medical Center
Oct 14, 2016
HSAN Type IV Trial (Droxidopa (L-DOPS), Placebo)
Withdrawn
- HSAN Type IV
- Droxidopa (L-DOPS)
- Placebo
- (no location specified)
Sep 9, 2016
Symptomatic Neurogenic Orthostatic Hypotension, Parkinson's Disease, Multiple Systems Atrophy Trial in New York, Charlotte,
Terminated
- Symptomatic Neurogenic Orthostatic Hypotension
- +4 more
- Droxidopa
- Placebo
-
New York, New York
- +2 more
Dec 4, 2015
Intradialytic Hypotension Trial in Medford (Droxidopa, Placebo)
Completed
- Intradialytic Hypotension
- Droxidopa
- Placebo
-
Medford, OregonRogue Valley Dialysis
May 27, 2014
Chronic Fatigue Syndrome, Orthostatic Hypotension, Neurally Mediated Hypotension Trial in Charlotte (Droxidopa)
Terminated
- Chronic Fatigue Syndrome
- +3 more
- Droxidopa
-
Charlotte, North Carolina7421 Carmel Executive Park Drive, Ste. 320
May 21, 2014
Parkinson Disease, Multiple System Atrophy, Autonomic Nervous System Diseases Trial run by the NINDS (Droxidopa, Carbidopa,
Terminated
- Parkinson Disease
- +2 more
- Droxidopa
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 17, 2014
Symptomatic Neurogenic Orthostatic Hypotension (NOH), Non-diabetic Neuropathy, Primary Autonomic Failure Trial in Canada, United
Completed
- Symptomatic Neurogenic Orthostatic Hypotension (NOH)
- +3 more
- Placebo
- Droxidopa
-
Huntsville, Alabama
- +20 more
Apr 22, 2014